JP2024506384A5 - - Google Patents
Info
- Publication number
- JP2024506384A5 JP2024506384A5 JP2023548873A JP2023548873A JP2024506384A5 JP 2024506384 A5 JP2024506384 A5 JP 2024506384A5 JP 2023548873 A JP2023548873 A JP 2023548873A JP 2023548873 A JP2023548873 A JP 2023548873A JP 2024506384 A5 JP2024506384 A5 JP 2024506384A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- patient
- roflumilast
- ophthalmic pharmaceutical
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163148008P | 2021-02-10 | 2021-02-10 | |
| US63/148,008 | 2021-02-10 | ||
| US202163261404P | 2021-09-20 | 2021-09-20 | |
| US63/261,404 | 2021-09-20 | ||
| PCT/US2022/015942 WO2022173923A1 (en) | 2021-02-10 | 2022-02-10 | Methods for ophthalmic delivery of roflumilast |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506384A JP2024506384A (ja) | 2024-02-13 |
| JP2024506384A5 true JP2024506384A5 (https=) | 2025-02-19 |
Family
ID=82704332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548873A Pending JP2024506384A (ja) | 2021-02-10 | 2022-02-10 | ロフルミラストの眼科的送達方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12102622B2 (https=) |
| EP (1) | EP4291162A4 (https=) |
| JP (1) | JP2024506384A (https=) |
| AU (1) | AU2022218993A1 (https=) |
| CA (1) | CA3206106A1 (https=) |
| IL (1) | IL304924A (https=) |
| MX (1) | MX2023009352A (https=) |
| WO (1) | WO2022173923A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023049809A1 (en) * | 2021-09-22 | 2023-03-30 | Iolyx Therapeutics, Inc. | Methods of treating ocular inflammatory diseases |
| AU2023341161A1 (en) * | 2022-09-16 | 2025-04-03 | Iolyx Therapeutics, Inc. | High concentration pharmaceutical compositions of roflumilast for ophthalmic delivery |
| WO2025024684A1 (en) * | 2023-07-25 | 2025-01-30 | Iolyx Therapeutics, Inc. | Ocular surface topical administration of roflumilast for treatment of anterior and retinal-vitreous chamber ocular diseases |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59410119D1 (de) | 1993-07-02 | 2002-06-20 | Byk Gulden Lomberg Chem Fab | Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren |
| SK122199A3 (en) | 1997-03-18 | 2000-12-11 | Basf Ag | Methods and compositions for modulating responsiveness to corticosteroids |
| PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
| US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
| US20040242597A1 (en) | 2001-09-19 | 2004-12-02 | Thomas Klein | Combination |
| PT1511516E (pt) | 2002-05-28 | 2009-02-20 | Nycomed Gmbh | Preparação farmacêutica para aplicação tópica |
| US20060263350A1 (en) | 2003-09-26 | 2006-11-23 | Fairfield Clinical Trials Llc | Combination antihistamine medication |
| AU2005267706B2 (en) | 2004-08-02 | 2011-12-08 | University Of Virginia Patent Foundation | 2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity |
| US7576069B2 (en) | 2004-08-02 | 2009-08-18 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
| DE102004046235A1 (de) | 2004-09-22 | 2006-03-30 | Altana Pharma Ag | Arzneimittelzubereitung |
| US8663694B2 (en) * | 2005-03-16 | 2014-03-04 | Takeda Gmbh | Taste masked dosage form containing roflumilast |
| DK1906916T3 (da) * | 2005-05-10 | 2009-01-19 | Alcon Inc | Oftalmisk suspension, der omfatter et oftalmisk lægemiddel, en poloxamin og et tonicitetsregulerende glycolbaseret middel, anvendelse af sammensætningen til fremstilling af et medikament til behandling af oftalmiske lidelser |
| BRPI0609227A2 (pt) | 2005-05-10 | 2010-03-09 | Alcon Inc | composições de suspensão de nepafenac e outros fármacos oftálmicos, bem como uso das referidas composições no tratamento tópico de distúrbios oftálmicos |
| EP1889620A4 (en) * | 2005-06-09 | 2008-12-10 | Santen Pharmaceutical Co Ltd | EYE DROPS CONTAINING ROFLUMILAST |
| JP2007016024A (ja) * | 2005-06-09 | 2007-01-25 | Santen Pharmaceut Co Ltd | ロフルミラスト点眼液 |
| US20090092574A1 (en) | 2006-12-29 | 2009-04-09 | Scott Richard W | Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof |
| CA2712017C (en) | 2008-01-18 | 2016-08-09 | Oxagen Limited | Compounds having crth2 antagonist activity |
| RS54413B1 (sr) | 2008-08-22 | 2016-04-28 | Sanofi | [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoksi-etil)-4trifluorometoksi-1h-indol-3-il]metanon kao inhibitor triptaze iz mastocita |
| EP2506878A2 (en) | 2009-12-03 | 2012-10-10 | Lupin Limited | Process for preparing pharmaceutical ophthalmic compositions |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| CN103547580B (zh) | 2011-03-22 | 2016-12-07 | 阿迪维纳斯疗法有限公司 | 取代的稠合三环化合物、其组合物及医药用途 |
| US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
| WO2014072937A1 (en) | 2012-11-08 | 2014-05-15 | Rhizen Pharmaceuticals Sa | Pharmaceutical compositions containing a pde4 inhibitor and a pi3 delta or dual pi3 delta-gamma kinase inhibitor |
| WO2014130922A1 (en) | 2013-02-25 | 2014-08-28 | Trustees Of Boston University | Compositions and methods for treating fungal infections |
| WO2015132708A1 (en) | 2014-03-07 | 2015-09-11 | Torrent Pharmaceuticals Limited | Pharmaceutical composition of roflumilast |
| WO2016024185A1 (en) | 2014-08-12 | 2016-02-18 | Pfizer Inc. | Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase |
| TW201729810A (zh) | 2015-10-26 | 2017-09-01 | 札爾科製藥公司 | 嘧啶組成物、其超純組成物及鹽類、製造彼之方法、及使用彼於治療組織胺h4受體(h 4 )仲介之疾病與病情之方法 |
| US9895359B1 (en) | 2017-06-07 | 2018-02-20 | Arcutis, Inc. | Inhibition of crystal growth of roflumilast |
| MX2021003633A (es) | 2018-10-16 | 2021-05-27 | Res Triangle Inst | Dispositivo de depósito biodegradable subcutáneo. |
| EP4061332A4 (en) | 2019-11-24 | 2023-11-29 | Sol-Gel Technologies Ltd. | TREATMENT OF SKIN DISEASES USING TOPICAL COMPOSITIONS CONTAINING TAPINAROF AND A PDE4 INHIBITOR |
| WO2023049809A1 (en) * | 2021-09-22 | 2023-03-30 | Iolyx Therapeutics, Inc. | Methods of treating ocular inflammatory diseases |
-
2022
- 2022-02-10 US US17/668,858 patent/US12102622B2/en active Active
- 2022-02-10 MX MX2023009352A patent/MX2023009352A/es unknown
- 2022-02-10 JP JP2023548873A patent/JP2024506384A/ja active Pending
- 2022-02-10 IL IL304924A patent/IL304924A/en unknown
- 2022-02-10 EP EP22753325.4A patent/EP4291162A4/en active Pending
- 2022-02-10 WO PCT/US2022/015942 patent/WO2022173923A1/en not_active Ceased
- 2022-02-10 AU AU2022218993A patent/AU2022218993A1/en active Pending
- 2022-02-10 CA CA3206106A patent/CA3206106A1/en active Pending
-
2024
- 2024-09-26 US US18/897,425 patent/US20250009724A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3681500B1 (en) | Use of pilocarpine hydrochloride for the treatment of presbyopia | |
| Rashad | Laser in situ keratomileusis for myopic anisometropia in children | |
| JP2024506384A5 (https=) | ||
| JP2006524185A5 (https=) | ||
| JP2015509500A5 (https=) | ||
| JP6014033B2 (ja) | 防腐剤無添加ビマトプロストおよびチモロール溶液 | |
| Stojanovic et al. | 200 Hz flying-spot technology of the LaserSight LSX excimer laser in the treatment of myopic astigmatism: six and 12 month outcomes of laser in situ keratomileusis and photorefractive keratectomy | |
| CN109996814A (zh) | 多激酶抑制剂及在眼部纤维化中的用途 | |
| MX2023009352A (es) | Metodos para la administracion oftalmica de roflumilast. | |
| JP2015523986A5 (https=) | ||
| RU2014151992A (ru) | Лечение воспалительных заболеваний глаз с применением лахинимода | |
| RU2707379C1 (ru) | Способ выбора параметров лазерного воздействия при лечении далекозашедшей и терминальной рефрактерной глаукомы | |
| Zheng et al. | Angle-closure glaucoma following periorbital botulinum toxin injection. | |
| RU2668703C1 (ru) | Способ хирургического лечения первичной открытоугольной глаукомы | |
| RU2164112C1 (ru) | Способ лечения постконтузионных повреждений глаза | |
| RU2743218C1 (ru) | Способ хирургической коррекции пресбиопии у лиц среднего и пожилого возраста - тканесохранный ЛАСИК | |
| Sakai et al. | Recurrent uveal effusion after laser iridotomy | |
| Espana et al. | Cyclodialysis cleft secondary to removal of an anterior chamber phakic intraocular lens | |
| RU2585400C2 (ru) | Лекарственная форма на основе бутиламиногидроксипропоксифеноксиметил метилоксадиазола | |
| US20250387331A1 (en) | Prostaglandin analogs and methods for sustained glaucoma management | |
| RU2688960C1 (ru) | Способ комбинированного хирургического лечения вторичной глаукомы, вызванной эмульгированием силикона | |
| RU2294183C2 (ru) | Способ проведения операции рефракционно-коррегирующей эксимерлазерной интрастромальной кератэктомии (рэик) | |
| Abdurakhmanovich et al. | Results of Staged Combined Laser Treatment of Neovascular Glaucoma | |
| RU2731885C2 (ru) | Способ профилактики пигментной глаукомы при синдроме пигментной дисперсии | |
| RU2638767C1 (ru) | Способ профилактики реактивной гипертензии после факоэмульсификации катаракты |